Joel Greenblatt's position in Ligand Pharmaceuticals is currently worth $294 Thousand. That's 0.01% of their equity portfolio (1106th largest holding). The first Ligand Pharmaceuticals trade was made in Q3 2013. Since then Joel Greenblatt bought shares eighteen more times and sold shares on seventeen occasions. The investor's estimated purchase price is $306 Thousand, resulting in a loss of 3.9%.